Similarly, mice deficient in IL-1α are protected against obesity-induced glucose intolerance; therefore, the blockade of IL1R1 and IL-1α could be used in the treatment of IR and obesity. Here, IL1R1 is linked to obesity due to melanocortin 4 receptor deficiency.